Power Law company profile

Relay Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.88B

Market cap · Apr/2026

Revenue

$15M

Latest reported FY

Investors

12 investors on Relay Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Third Rock Ventures

Series B+ 11 investors entered at this stage

SoftBank

Foresight Group

Casdin Capital

Alexandria Venture Investments

Global footprint

Where Relay Therapeutics has talent and traffic

Web traffic by country

13K monthly visits
across markets

🇺🇸 United States53.8%

🇮🇳 India18.5%

🇬🇧 United Kingdom15.4%

🇯🇵 Japan9.2%

🇩🇪 Germany1.5%

Top 5 markets shown

Patent intelligence

$14M patent portfolio · 37 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$14M

0.72% of market cap · 1.9× smaller than top peer Kymera Therapeutics ($26M)

37 active patent families

Where Relay Therapeutics innovates BiochemistryPharmacologyMolecular biologyPhosphatase inhibitorDepressant

Above peer median on Technology

Quality vs same-sector peers

Relay Therapeutics on the five Patsnap quality dimensions

Relay Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Relay Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Relay Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Relay Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo